UnitedHealth Group CEO Andrew Witty, during the company’s first earnings call since the death of executive Brian Thompson, criticized the U.S. healthcare system’s complexity and high costs, driven by a profit-focused model where high costs benefit many participants. Witty specifically cited discrepancies in drug pricing, blaming pharmaceutical companies while asserting UnitedHealth’s efforts to improve transparency. Despite record 2024 revenues, the company reported worse-than-expected quarterly results, and Witty reaffirmed the company’s commitment to improving the system.
Read More
UnitedHealth Group reported mixed earnings results following the recent murder of executive Brian Thompson, an event that sparked public criticism of the company’s healthcare practices. CEO Andrew Witty defended the company’s role in lowering costs, attributing high prices to pharmaceutical companies and healthcare providers, while acknowledging the need for a less complex and costly US healthcare system. Witty highlighted ongoing efforts to improve the healthcare approval process and reaffirmed the company’s commitment to fully passing on drug price negotiation savings to customers. The company aims to address public concerns regarding healthcare access and affordability.
Read More
In response to President-elect Trump’s repeated suggestions that Canada become the 51st U.S. state, Canadian Green Party leader Elizabeth May proposed a counter-offer. May jokingly suggested that California, Oregon, and Washington join Canada as provinces, highlighting the benefits of Canadian universal healthcare and stricter gun control laws. This counter-proposal underscores the contrasting values between the two nations and the potential for strained relations following Trump’s comments and proposed tariffs on Canadian goods. Various Canadian officials have publicly rejected Trump’s annexation suggestions.
Read More
Shareholders are urging UnitedHealth to conduct a thorough analysis of the impact of its healthcare denials. This demand comes amidst growing public outcry and negative press surrounding the company’s practices, which many perceive as prioritizing profits over patient well-being. The shareholders clearly understand that this negative publicity is directly impacting the company’s bottom line, potentially affecting stock prices and investor confidence.
The urgency behind this request is palpable. The sheer volume of complaints suggests a systemic issue. One individual recounts a deeply personal experience where their wife’s epilepsy medication was denied, despite having refills remaining, resulting in a significant out-of-pocket expense.… Continue reading
A new Biden administration rule will eliminate $49 billion in medical debt from the credit reports of over 15 million Americans, effectively preventing its use in loan applications. This action, praised by Vice President Harris as “lifechanging,” is projected to boost credit scores by an average of 20 points and facilitate thousands of additional mortgage approvals annually. The rule addresses the issue of medical debt’s inaccurate prediction of repayment ability, building upon prior efforts by credit reporting agencies to remove smaller medical debts. The initiative complements over $1 billion in state and local medical debt relief already enacted using pandemic aid funds.
Read More
The Biden administration’s recent move to ban medical debt from credit reports is a significant step towards addressing a long-standing problem in the American healthcare system. This action directly impacts millions of Americans burdened by medical debt, a situation often arising through no fault of their own.
This initiative aims to alleviate the financial strain on individuals struggling to manage healthcare costs. High medical expenses frequently result in unpaid bills, which then negatively affect credit scores, creating a vicious cycle of financial hardship. By removing this type of debt from credit reports, the administration hopes to give individuals a fresh start and a fairer chance to rebuild their financial lives.… Continue reading
A Covid surge is currently underway in the U.S., driven by low booster uptake (only 21.4% of adults and 10.3% of children have received the latest booster) and the emergence of new variants. Increased test positivity, hospitalizations, and deaths underscore the ongoing danger of the virus, particularly for the elderly and vulnerable populations. Experts emphasize the continued need for vaccination, monitoring, and preventive measures like masking and improved air quality, though the prioritization of these measures remains uncertain under the new administration. The virus’s unpredictable behavior highlights the importance of ongoing surveillance and rapid response to future waves.
Read More
The lack of widespread mourning following the death of UnitedHealthcare CEO Brian Thompson reflects deep-seated public anger towards the healthcare insurance industry’s profiteering practices. This anger stems from insurers prioritizing profits over patient care, leading to denied claims, unaffordable costs, and compromised healthcare access. The overwhelmingly negative public reaction underscores the urgent need for systemic reform, as current attempts at regulation have failed to address the core issue of prioritizing corporate profits over patient well-being. A single-payer national health program is presented as a potential solution to alleviate the suffering caused by the current system.
Read More
Drugmakers are set to raise prices on over 250 medications in the US starting January 1st. This news has unsurprisingly sparked widespread outrage and frustration, especially given the timing – just as many are facing economic challenges. The increases, it’s important to note, apply to list prices. These are the prices before rebates and discounts are factored in, meaning pharmacy benefit managers and other intermediaries will likely still receive significant concessions while consumers bear the brunt of the increase.
This raises immediate questions about fairness and accessibility. Many have voiced concerns that those who rely on these medications for chronic or rare conditions will struggle to afford the higher costs, potentially facing life-altering consequences.… Continue reading
A new NORC poll reveals that a substantial majority of Americans (69%) believe health insurance claim denials significantly contributed to the murder of UnitedHealthcare CEO Brian Thompson, with 67% citing the company’s substantial profits as a contributing factor. The killer’s alleged motive seemingly reflects the industry’s “delay, deny, defend” strategy, evidenced by inscriptions on crime scene ammunition. While 78% attributed a significant role to the shooter, a notable portion of respondents also linked Thompson’s death to broader societal issues, such as wealth inequality. The poll highlights widespread public frustration with the healthcare system and its associated financial burdens.
Read More
John Q. Hosedrinker 
Matt Underwood